A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like Ozempic and Wegovy. Starting in 2026, some versions could cost just $149 monthly via a new platform. Medicare enrollees with specific health risks will see a $50 copay, making these treatments more accessible and potentially reducing long-term healthcare costs.source https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/weight-loss-gets-cheaper-new-white-house-deal-slashes-prices-of-ozempic-and-wegovy/articleshow/125140822.cms